Antibiotics are a crucial tool in the fight against bacterial infections. But the World Health Organization has long warned that we are facing an antibiotic crisis. Bacteria can easily adapt, evolve, ...

Antibiotics have been a cornerstone of modern medicine, saving countless lives since their discovery. However, the world is now facing an alarming rise in antibiotic-resistant bacteria, which ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.

Although the past decade has been marked by lack of innovation in the field of antibiotics development, that trend is changing, according to data from Reportlinker. According to the data, 109 ...

As the world grapples with the daunting challenge of antibiotic-resistant superbugs, a ray of hope emerges from the scientific community. Recent strides in medical research have led to the development ...

Investor enthusiasm and evolving FDA pathways are accelerating rare disease drug development, with ultrarare conditions like ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

DENVER The last time a new tuberculosis drug was developed, Richard Nixon was in the White House. That drug, Rifampin, "was the biggest thing to hit TB in 30 years," said Dr. Michael Iseman, a ...